CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to HLUYY

Agomelatine

Phase 3
Lundbeck (HLUYY)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

4

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Drug Information

Target Indication

Major Depressive Disorder

Clinical Trial

NCT01488071

Last updated: 12/24/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Regulatory Approvals
EMAPending

Thymanax

View on EMA
EMAPending

Valdoxan

View on EMA
EMA2/19/2009

Thymanax

Treatment of major depressive episodes in adults.

View on EMA
EMA2/19/2009

Valdoxan

Treatment of major depressive episodes in adults.

View on EMA
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.